Effects of streptozotocin- and alloxan-induced diabetes mellitus on mouse follicular and early embryo development

Michael Peter Diamond, K. H. Moley, A. Pellicer, W. K. Vaughn, A. H. DeCherney

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Mice were made diabetic by intraperitoneal injection of streptozotocin or alloxan. Germinal vesicle breakdown in the ovarian follicles at 8 h after hCG in control animals (57%) was significantly greater than in streptozotocin-(24%) and alloxan-(42%) diabetic animals (P < 0.001). This delay in oocyte maturation was reversible by in-vivo insulin administration to diabetic mice. A developmental delay was also found for embryos recovered from diabetic mice. This developmental delay extended into the 72 h in-vitro cultures. Compared to control embryos, those from alloxan- and streptozotocin-treated mice demonstrated marked impairment in development as assessed by (1) distribution of developmental cell stages at each observation period and (2) rates of development which increasingly diverged at each observation period. In diabetic mice treated with insulin in vivo, the percentage of 2-cell embryos recovered increased. Furthermore, in streptozotocin- and alloxan-animals treated with insulin, the rate of in-vitro development of embryos, as well as their developmental stage distribution improved. We therefore suggest that uncontrolled diabetes mellitus, as well as contributing to the development of congenital malformations, may deleteriously affect reproductive performance both before fertilization and at the very earliest gestational stages.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalJournal of Reproduction and Fertility
Volume86
Issue number1
DOIs
StatePublished - Jan 1 1989

Fingerprint

Experimental Diabetes Mellitus
Streptozocin
Alloxan
Embryonic Development
Diabetes Mellitus
Embryonic Structures
Insulin
Observation
Ovarian Follicle
Intraperitoneal Injections
Fertilization
Oocytes

ASJC Scopus subject areas

  • Physiology
  • Embryology
  • Molecular Biology
  • Obstetrics and Gynecology
  • Developmental Biology

Cite this

Effects of streptozotocin- and alloxan-induced diabetes mellitus on mouse follicular and early embryo development. / Diamond, Michael Peter; Moley, K. H.; Pellicer, A.; Vaughn, W. K.; DeCherney, A. H.

In: Journal of Reproduction and Fertility, Vol. 86, No. 1, 01.01.1989, p. 1-10.

Research output: Contribution to journalArticle

@article{93727398eb2a4f868708179b9c76388e,
title = "Effects of streptozotocin- and alloxan-induced diabetes mellitus on mouse follicular and early embryo development",
abstract = "Mice were made diabetic by intraperitoneal injection of streptozotocin or alloxan. Germinal vesicle breakdown in the ovarian follicles at 8 h after hCG in control animals (57{\%}) was significantly greater than in streptozotocin-(24{\%}) and alloxan-(42{\%}) diabetic animals (P < 0.001). This delay in oocyte maturation was reversible by in-vivo insulin administration to diabetic mice. A developmental delay was also found for embryos recovered from diabetic mice. This developmental delay extended into the 72 h in-vitro cultures. Compared to control embryos, those from alloxan- and streptozotocin-treated mice demonstrated marked impairment in development as assessed by (1) distribution of developmental cell stages at each observation period and (2) rates of development which increasingly diverged at each observation period. In diabetic mice treated with insulin in vivo, the percentage of 2-cell embryos recovered increased. Furthermore, in streptozotocin- and alloxan-animals treated with insulin, the rate of in-vitro development of embryos, as well as their developmental stage distribution improved. We therefore suggest that uncontrolled diabetes mellitus, as well as contributing to the development of congenital malformations, may deleteriously affect reproductive performance both before fertilization and at the very earliest gestational stages.",
author = "Diamond, {Michael Peter} and Moley, {K. H.} and A. Pellicer and Vaughn, {W. K.} and DeCherney, {A. H.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1530/jrf.0.0860001",
language = "English (US)",
volume = "86",
pages = "1--10",
journal = "Journal of Reproduction and Fertility",
issn = "0022-4251",
publisher = "Society for Reproduction and Fertility",
number = "1",

}

TY - JOUR

T1 - Effects of streptozotocin- and alloxan-induced diabetes mellitus on mouse follicular and early embryo development

AU - Diamond, Michael Peter

AU - Moley, K. H.

AU - Pellicer, A.

AU - Vaughn, W. K.

AU - DeCherney, A. H.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Mice were made diabetic by intraperitoneal injection of streptozotocin or alloxan. Germinal vesicle breakdown in the ovarian follicles at 8 h after hCG in control animals (57%) was significantly greater than in streptozotocin-(24%) and alloxan-(42%) diabetic animals (P < 0.001). This delay in oocyte maturation was reversible by in-vivo insulin administration to diabetic mice. A developmental delay was also found for embryos recovered from diabetic mice. This developmental delay extended into the 72 h in-vitro cultures. Compared to control embryos, those from alloxan- and streptozotocin-treated mice demonstrated marked impairment in development as assessed by (1) distribution of developmental cell stages at each observation period and (2) rates of development which increasingly diverged at each observation period. In diabetic mice treated with insulin in vivo, the percentage of 2-cell embryos recovered increased. Furthermore, in streptozotocin- and alloxan-animals treated with insulin, the rate of in-vitro development of embryos, as well as their developmental stage distribution improved. We therefore suggest that uncontrolled diabetes mellitus, as well as contributing to the development of congenital malformations, may deleteriously affect reproductive performance both before fertilization and at the very earliest gestational stages.

AB - Mice were made diabetic by intraperitoneal injection of streptozotocin or alloxan. Germinal vesicle breakdown in the ovarian follicles at 8 h after hCG in control animals (57%) was significantly greater than in streptozotocin-(24%) and alloxan-(42%) diabetic animals (P < 0.001). This delay in oocyte maturation was reversible by in-vivo insulin administration to diabetic mice. A developmental delay was also found for embryos recovered from diabetic mice. This developmental delay extended into the 72 h in-vitro cultures. Compared to control embryos, those from alloxan- and streptozotocin-treated mice demonstrated marked impairment in development as assessed by (1) distribution of developmental cell stages at each observation period and (2) rates of development which increasingly diverged at each observation period. In diabetic mice treated with insulin in vivo, the percentage of 2-cell embryos recovered increased. Furthermore, in streptozotocin- and alloxan-animals treated with insulin, the rate of in-vitro development of embryos, as well as their developmental stage distribution improved. We therefore suggest that uncontrolled diabetes mellitus, as well as contributing to the development of congenital malformations, may deleteriously affect reproductive performance both before fertilization and at the very earliest gestational stages.

UR - http://www.scopus.com/inward/record.url?scp=0024555292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024555292&partnerID=8YFLogxK

U2 - 10.1530/jrf.0.0860001

DO - 10.1530/jrf.0.0860001

M3 - Article

C2 - 2526873

AN - SCOPUS:0024555292

VL - 86

SP - 1

EP - 10

JO - Journal of Reproduction and Fertility

JF - Journal of Reproduction and Fertility

SN - 0022-4251

IS - 1

ER -